Naoki Hijiya

5PUBLICATIONS
14CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jan 29, 2026
Annexin A8 Drives MEK Inhibitor Resistance, Providing a Druggable Target for Pancreatic Ductal Adenocarcinoma.

Shusaku Kurogi, Yoshiyuki Tsukamoto, Junpei Yamamura

|Sep 16, 2023
Association of immune-related expression profile with sensitivity to chemotherapy in esophageal squamous cell carcinoma.

Yoshiyuki Tsukamoto, Shusaku Kurogi, Hajime Fujishima

|Nov 19, 2017
Downregulation of dual-specificity phosphatase 4 enhances cell proliferation and invasiveness in colorectal carcinomas.

Michihiro Ichimanda, Naoki Hijiya, Yoshiyuki Tsukamoto

Pageof 1